Cerebrospinal-fluid profile in neuroborreliosis and its diagnostic significance

Folia Microbiologica

Volumn 51, Issue 6, 2006, Pages 599-603

  Bednarova J ^a  

^a UNIVERSITY HOSPITAL BRNO   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; SERUM ALBUMIN;

ARTICLE; BLOOD BRAIN BARRIER; BORRELIA BURGDORFERI; CEREBROSPINAL FLUID; CHEMISTRY; CYTOCHEMISTRY; CYTOLOGY; DIFFERENTIAL DIAGNOSIS; HUMAN; IMMUNOLOGY; LYME DISEASE; NEUROLOGIC DISEASE;

ANTIBODIES, BACTERIAL; BLOOD-BRAIN BARRIER; BORRELIA BURGDORFERI GROUP; CEREBROSPINAL FLUID; DIAGNOSIS, DIFFERENTIAL; HISTOCYTOCHEMISTRY; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LYME NEUROBORRELIOSIS; NERVOUS SYSTEM DISEASES; SERUM ALBUMIN;

BORRELIA;

EID: 33847144224     PISSN: 00155632     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02931625     Document Type: Article

References (33)

1. ADAM P., TÁBORSKÝ L., SOBEK O., HILDEBRAND T., KELBICH T., PRŮCHA M., HYÁNEK J.: Cerebrospinal fluid. Adv.Clin.Chem. 36, 1-62 (2001).
2. ADAM P., SOBEK O., TÁBORSKÝ L., HILDEBRAND T., PRŮCHA M., HYÁNEK J., ŽÁČEK P., VESELÁ B.: Complete proteinogram of cerebrospinal fluid and its contribution to the diagnostics of inflammatory and autoimmune diseases of the central nervous system. 1st Fac.Med.Charles Univ.Quart.J. 104, 1-12 (2003a).
3. 1-glycoprotein) levels in MS patients subgroups. Clin.Chim.Acta 334, 107-110 (20036).
4. BERGLUND J., STJERNBERG L., ORNSTEIN K., TAKESSON-JOELSSON K., WALTER H.: Five-year follow-up study of patients with neuroborreliosis. Scand.J.Infect.Dis. 34, 421-425 (2002).
5. UNIEWICZ M., ADAM P.: Neuro-Infective Diseases. Maxdorf-Jesenius, Prague 1999.
6. FELGENHAUER K.: Laboratory diagnosis of neurological diseases, pp. 1308-1326 in L. Thomas: Clinical Laboratory Diagnostics - Use and Assessment of Clinical Laboratory Results. TH Books, Frankfurt a.M. (Germany) 1998.
7. HAMMERS-BERGGREN S., LEBECH A.M., KARLSSON M., SVENUNGSSON B., HANSEN K., STIERNSTEDT G.: Serological follow-up after treatment of patients with erythema migrans and neuroborreliosis. J.Clin.Microbiol. 32, 1519-1525 (1994).
8. JANOVSKÁ D.: Lyme borreliosis - epidemiology in the Czech Republic, pp. 19-32 in P. Bartůněk: Lyme Borreliosis. (In Czech) Grada Publishing, Prague 2001.
9. KAISER R.: Variable CSF findings in early and late Lyme neuroborreliosis: a follow-up study in 47 patients. J.Neural. 242, 26-36 (1994).
10. KAISER R.: Neuroborreliosis. J.Neurol. 245, 247-255 (1998).
11. ODIN Z.: Inflammatory and autoimmune diseases of the nervous system: possibilities of laboratory diagnostic methods in cerebrospinal fluid. Folia Microbiol. 48, 839-847 (2003).
12. OSCHMANN P., DORNDORF W., HORNIG C., SCHÄFER C., WELLENSIEK HJ., PFLUOHAUPT K.W.: Stages and syndromes of neuroborreliosis. J. Neural 245, 262-272 (1998).
13. REIBER H.: Cerebrospinal fluid analysis, pp. 51-72 in E.J. Thompson, M. Trojano, P. Livrea: CSF Analysis in Multiple Sclerosis. Springer-Verlag, Milano (Italy) 1996.
14. REIBER H.: Cerebrospinal fluid - physiology, analysis and interpretation of protein patterns for diagnosis of neurological diseases. Mult. Scler. 4, 99-107 (1998).
15. REIBER H., LANGE P.: Quantification of virus-specific antibodies in Cerebrospinal fluid and serum: sensitive and specific detection of antibody synthesis in brain. Clin.Chem. 37, 1153-1160 (1991).
16. REIBER H., PETER J.B.: Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs. J.Neurol.Sci. 184, 101-122 (2001).
17. REIBER H., THOMPSON E.J., GRIMSLEY G., BERNARDI G., ADAM P., MONTEIRO DE ALMEIDA S., FREDMAN F., KEIR G., LAMMERS L., LIBLAU R., MENNA-BARRETO M., SA M.J., SERES M., SINDIC C.J.M., TEELKEN A., TRENDELENBURG C., TROJANO M., VAN ANTWERPEN M., VERBEEKET M.M.: Quality assurance for cerebrospinal fluid analysis: international consensus by an internet-based group discussion. Clin.Chem.Lab.Med. 41, 331-337 (2003).
18. ROBERTSON J., GUY E., ANDREWS N., WILSKE B., ANDA P., GRANSTRÖM M., HAUSER U., MOOSMANN Y., SAMBRI V., SCHELLEKENS J., STANEK G., GRAY J.: A European Multicenter study of immunoblotting in serodiagnosis of Lyme borreliosis. J.Clin. Microbiol. 38, 2097-2102 (2000).
19. RUDENKO N., GOLOVCHENKO M., NĚMEC J., VOLKAERT J., MALLATOVA N., GRUBHOFFER L.: Improved method of detection and molecular typing of Borrelia burgdorferi sensu lato in clinical samples by polymerase chain reaction without DNA purification. Folia Microbiol. 50, 31-39 (2005).
20. SCHWARZOVA K., ČIŽNÁR I.: Combined infection of Ixodes ricinus with three Borrelia burgdorferi sensu lato genotypes. Folia Microbiol. 49, 297-301 (2004).
21. SEVERINOVÁ J., SALÁT J., KROČOVÁ Z., ŘEZNÍČKOVÁ J., DEMOVÁ H., HORKÁ H., KOPECKÝ J.: Co-inoculation of Borrelia afzelii with tick salivary gland extract influences distribution of immunocompetent cells in the skin and lymph nodes of mice. Folia Microbiol. 50, 457-466 (2005).
22. SOBER O., ADAM P., ZEMAN D., KELBICH P., TAUBEROVA A., TYL D.: Cerebrospinal fluid parameters in patients with neuroborreliosis. Klin.Biochem.Metab. 6, 229-234 (1998).
23. SOBEK O., ADAM P., TABORSRÝ L., HILDEBRAND T., KELBICH T., PRÚCHA M., HYANEK J.: Neuroborreliosis. Adv.Clin.Chem. 36, 39-45 (2001).
24. SOBEK O., ADAM P., TÁBORSKÝ L., PRŮCHA M., VESELA B.: Acute and chronical forms of neuroborreliosis - cerebrospinal fluid differential diagnostics. Klin.Biochem.Metab. 10, 43-50 (2002).
25. SOBER O., ADAM P.: Letter to the editors: on S. Seyfert, V. Kunzrnann, N. Schwertfeger, H.C. Koch, A. Faulstich: Determinants of lumbar CSF protein concentration. J.Neurol. 250, 371-372 (2003).
26. ŠTOURAČ P.: Oligoclonal synthesis of IgG in auto-immune neurological paraneoplastic syndromes. Klin.Biochem.Metab. 8, 224-228 (2000).
27. ŠTOURAČ P., KADAŇKA Z., PALYZA V.: Paraneoplastic neurological syndromes - patients' cohort profile in the Czech Republic. Acta Neurol.Scand. 104, 72-77 (2001).
28. TÁBORSKÝ L., ADAM P., SOBEK O., DOSTÁL M.: Levels of apolipoprotein A-II in cerebrospinal fluid in patients with neuroborreliosis are associated with lipophagocytosis. Folia Microbiol. 48, 849-850 (2003).
29. TUMANI H., NÖLKER G., REIBER H.: Relevance of cerebrospinal fluid variables for early diagnosis of neuroborreliosis. Neurology 45, 1663-1670 (1995).
30. ANCOVÁ M., NEBESÁŘOVÁ J., GRUBHOFFER L.: Lectin-binding characteristics of a Lyme borreliosis spirochete Borrelia burgdorferi sensu stricto. Folia Microbiol. 50, 229-238 (2005).
31. RETHEM M., HELLBLOM L., WIDLUND M., AHL M., DANIELSSON O., ERNERUDH J., FORSBERG P.: Chronic symptoms are common in patients with neuroborreliosis - a questionnaire follow-up study. Acta Neurol.Scand. 106, 205-208 (2002).
32. ZEMAN D., ADAM P., KALISTOVA H., SOBEK O., KELBICH P., ANDĚL J., ANDĚL M.: Transferrin in patients with multiple sclerosis: a comparison among various subgroups of multiple sclerosis patients. Acta Neurol.Scand. 101, 89-94 (2000).
33. ZEMAN D., ADAM P., KALISTOVÁ H., SOBER O., ANDĚL J., ANDĚL M.: Cerebrospinal fluid cytological findings in multiple sclerosis: a comparison between patient subgroups. Acta Cytol. 45, 51-59 (2001).